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CLN1 disease (OMIM #256730) is an inherited neurological disorder of early childhood
with epileptic seizures and premature death. It is associated with mutations in CLN1
coding for Palmitoyl-Protein Thioesterase 1 (PPT1), a lysosomal enzyme which affects
the recycling and degradation of lipid-modified (S-acylated) proteins by removing
palmitate residues. Transcriptomic evidence from a neuronal-like cellular model derived
from differentiated SH-SY5Y cells disclosed the potential negative roles of CLN1
overexpression, affecting the elongation of neuronal processes and the expression of
selected proteins of the synaptic region. Bioinformatic inquiries of transcriptomic data
pinpointed a dysregulated expression of several genes coding for proteins related to
voltage-gated ion channels, including subunits of calcium and potassium channels
(VGCC and VGKC). In SH-SY5Y cells overexpressing CLN1 (SH-CLN1 cells), the resting
potential and the membrane conductance in the range of voltages close to the resting
potential were not affected. However, patch-clamp recordings indicated a reduction of
Ba2+ currents through VGCC of SH-CLN1 cells; Ca2+ imaging revealed reduced Ca2+
influx in the same cellular setting. The results of the biochemical and morphological
investigations of CACNA2D2/α2δ-2, an accessory subunit of VGCC, were in accordance
with the downregulation of the corresponding gene and consistent with the hypothesis
that a lower number of functional channels may reach the plasma membrane. The
combined use of 4-AP and NS-1643, two drugs with opposing effects on Kv11 and
Kv12 subfamilies of VGKC coded by the KCNH gene family, provides evidence for
reduced functional Kv12 channels in SH-CLN1 cells, consistent with transcriptomic data
indicating the downregulation of KCNH4. The lack of compelling evidence supporting
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the palmitoylation of many ion channels subunits investigated in this study stimulates
inquiries about the role of PPT1 in the trafficking of channels to the plasma membrane.
Altogether, these results indicate a reduction of functional voltage-gated ion channels
in response to CLN1/PPT1 overexpression in differentiated SH-SY5Y cells and provide
new insights into the altered neuronal excitability which may underlie the severe epileptic
phenotype of CLN1 disease. It remains to be shown if remodeling of such functional
channels on plasma membrane can occur as a downstream effect of CLN1 disease.
Keywords: differentiated SH-SY5Y neuroblastoma cells, CLN1/PPT1 overexpression, transcriptomics,
bioinformatics, patch-clamp recording, calcium imaging, voltage-gated ion channels, CLN1 disease
INTRODUCTION
Mutations in CLN1, coding for the Palmitoyl-Protein
Thioesterase 1 (PPT1) enzyme, are associated with CLN1
disease (OMIM #256730), a progressive, neurodegenerative
disorder of childhood, characterized by acquired microcephaly,
hypotonia, delayed psychomotor development followed by
deterioration, untreatable seizures and myoclonus, truncal
ataxia, and involuntary movements. Children are bedridden
by 5–6 years of age, and the fatal outcome occurs by the end
of the second decade (Santavuori et al., 1973; Vesa et al.,
1995; Mitchison et al., 1998; Simonati et al., 2009). Atypical
presentations with an early adult onset have been described
(Van Diggelen et al., 2001). The reduced activity of PPT1 is the
biomarker of the disease (Hofmann et al., 1997).
PPT1 is a soluble hydrolytic lysosomal enzyme, highly
expressed in neuronal cells, which is involved in the degradation
of S-acylated proteins by removing the palmitate residues and
generating de-palmitoylated proteins suitable for proteasomal
degradation and/or recycling. Moreover, it is involved in the
regulation of luminal lysosomal acidification (Bagh et al., 2017).
In neurons, it is localized in other cellular compartments (such
as axons and specialized neural endings) where its enzymatic
activity may be conveyed at neutral pH. PPT1 regulates axonal
outgrowth as well as dendritic spine number and morphology,
thus influencing the pathfinding process and the stabilization
of neuronal connectivity (Suopanki et al., 1999; Kang et al.,
2008; Holland and Thomas, 2017; Koster and Yoshii, 2019).
PPT1 is also associated with several cell functions, including
autophagy and mTOR signaling whose regulators are predicted
to be palmitoylated proteins (Rebecca et al., 2017).
Palmitoylation, the covalent modification of a protein by
S-acylation with palmitate, affects maturation, sorting and
trafficking of proteins to specific subcellular compartments
(Fukata and Fukata, 2010). Control of palmitoylation occurs via
Abbreviations: 4-AP, 4-aminopyridine; 1F/F0, fluorescence normalized to basal
fluorescence; Cm, membrane capacitances; DEG, Differentially Expressed Gene;
FDR, False Discovery Rate; FPKM, Fragments Per Kilobase per Million mapped
reads; log2FC, Log2 fold change; PPT1, Palmitoyl-Protein Thioesterase 1; PK,
Proteinase K; RA-NBM, differentiation medium (all-trans-Retinoic Acid and
enriched Neurobasal medium); SH-mock, pcDNA3 (empty vector) transfected
cell line; SH-CLN1, CLN1-transfected cell line; VGCC, Voltage-gated Calcium
Channels; VGKC (or Kv), Voltage-gated Potassium Channels; VGIC, Voltage-
gated Ion Channels.
the balance between thioesterases catalyzing the breakdown of
the thioester bond, and several enzymes catalyzing its formation.
This fine dynamic cycle of palmitoylation/de-palmitoylation is
particularly relevant for neurons, since it has been reported
that the nervous system alone expresses over 40% of mouse
palmitoylome (Sanders et al., 2015). However, despite the
availability of animal models KO for CLN1, the functional roles
as well as the identification of putative substrates of PPT1 in the
brain remain somewhat unclear.
In neuronal endings, palmitoylation dynamically regulates the
recycling of synaptic vesicles and eventually neurotransmission
(Holz and Zimmerberg, 2019; Kreutzberger et al., 2019).
Moreover, palmitoylation is a developmentally regulated
process affecting plasma membrane remodeling, including
the maturation and specification of post-synaptic receptors
(Patterson and Skene, 1999; El-Husseini et al., 2002; Tulodziecka
et al., 2016). In the post-synaptic microdomain the functional
activities of both excitatory and inhibitory receptors are also
modulated by palmitoylation (Hayashi et al., 2009; Fukata et al.,
2013; Han et al., 2015; Hayashi, 2015; Jeyifous et al., 2016;
Itoh et al., 2018). Therefore, it can be assumed that mutated
PPT1 affects the turnover of palmitoylated proteins particularly
enriched in the synaptic compartment, possibly leading to
synaptic dysfunction at both the pre- and postsynaptic regions
(Kim et al., 2008; Kielar et al., 2009; Finn et al., 2012; Koster
et al., 2019), which may be related to the severe epileptogenicity
observed in CLN1 disease.
Multiomic technologies have been utilized in order to depict
the molecular network of interacting partners of PPT1, in terms
of protein-protein interactions (putative substrates) as well as
molecular nodes and pathways, which are affected downstream
to PPT1 (Scifo et al., 2015; Tikka et al., 2016; Kline et al., 2019;
Sapir et al., 2019). In differentiated SH-SY5Y cells overexpressing
CLN1, the expression of genes related to the elongation and
branching of neuronal structures (including transcripts coding
for palmitoylated neuropeptides) was dysregulated. Furthermore,
a transcriptional network enclosing several components of the
synaptic release machinery and ion channels subunits was
identified in the same overexpression system (Pezzini et al.,
2017b).
We exploited the observation that a group of genes affected
by PPT1 overexpression code for integral membrane proteins
belonging to distinct superfamilies of voltage-gated ion channels
(VGIC), opening the possibility of correlating transcriptional
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changes with their functional impact via patch-clamp recordings.
At present, no data related to the behavior of VGIC associated
with altered expression of CLN1 are available. Likewise, little
is known about the electrical properties and VGIC behavior
of SH-SY5Y cells differentiated into a neuronal-like phenotype.
By investigating both voltage- gated calcium and potassium
channels in differentiated SH-SY5Y cells overexpressing CLN1,
we aimed to obtain new insights on neuronal excitability and the
putative molecular mechanisms as suggested by bioinformatic
evaluation and functional annotations. In the long run, the
ultimate goal of this study was to contribute to the identification
of appropriate molecular targets to alleviate some of the
severe clinical manifestations of CLN1 disease, including the
drug-resistant epilepsy.
MATERIALS AND METHODS
Cell Lines Culture and Differentiation
SH-SY5Y neuroblastoma cells were cultured in DMEM-High
glucose medium supplemented with 15% Fetal Bovine Serum
(FBS), 2mM L-glutamine and 1% non-essential amino acids.
Clones overexpressing CLN1 (SH-CLN1) were generated by
transfection with pcDNA3 expression vector in which CLN1
cDNA (NM_000310) was inserted. Cells transfected with the
empty vector alone (mock cells; SH-mock) were used as controls.
Following antibiotic selection, the isolated clones were then
characterized at molecular as well as biochemical level. To
induce a more mature neuronal-like phenotype, mock and CLN1
overexpressing cells were differentiated following a combined
approach of retinoic acid and enriched neurobasal medium (RA-
NBM). Cells were pre-differentiated for 6 days in RA-containing
medium. Next, the medium was changed, and cells were
cultured in enriched Neurobasal medium (NBM): this point was
considered as day 0 for the electrophysiological study. From day
3, cells were maintained in the same medium and recorded up to
day 11 from the start of the differentiation paradigm in enriched
NBM. For transcriptomic, morphological as well as biochemical
investigations, cells were collected after 3 days in enriched NBM
medium [corresponding at day 9 of the original differentiation
paradigm previously described in Pezzini et al. (2017a,b)].
Bioinformatic Analysis of SH-CLN1
Transcriptomic Profile
The transcriptomic profiles of both mock- and CLN1-
overexpressing SH-SY5Y cells were previously generated by
RNAseq, placed in NCBI’s Gene Expression Omnibus and made
accessible through GEO Series accession number GSE98834
(Pezzini et al., 2017b). Normalized expression values (calculated
as Fragments Per Kilobase per Million mapped reads, FPKM) of
each gene was then compared between the two profiles to retrieve
differentially expressed genes (DEGs) of SH-CLN1 cells. The
ratio between average FPKM of SH-CLN1 profile and average
FPKM of mock profile was calculated and reported as log2 fold
change (log2FC): transcripts showing a |log2(FC)|≥1 and a False
Discovery Rate (FDR, q-value)≤0.05 were assigned as DEGs and
utilized as input for bioinformatic inquires.
Functional analysis was performed by QIAGEN’s Ingenuity R©
Pathway Analysis (IPA R©). Core Analysis was carried out to
find most significant functional annotations associated with the
differentially expressed genes and to create molecular networks;
statistical significance was ascertained by right-tailed Fisher’s
Exact Test following Benjamini and Hochberg (B-H) correction.
Z-score was also evaluated to predict the activation or inhibition
of a given biological function. To compare independent
Core Analyses, we selected the most meaningful functional
annotations (p < 0.05 and |z-score|>1) assigned to SH-CLN1
profile. Free-license databases were also utilized to link the
obtained expression profiles to specific cellular processes and/or
cellular domains (ToppGeneSuite, https://toppgene.cchmc.org/
enrichment.jsp). Cytoscape software (version 3.7.2, http://
www.cytoscape.org/) was utilized to draw networks starting
from selected GO terms. Lastly, palmitoyl-proteome databases
[including, SwissPalm-Protein S-palmitoylation database, http://
swisspalm.epfl.ch/; (Blanc et al., 2019)] were inquired to
recognize differentially expressed proteins in SH-CLN1 cells that
have been already reported to be modified by palmitoylation.
Electrophysiology
Perforated Patch-clamp Recording
Cells, either mock- or CLN1-transfected, were plated on 13mm
diameter round coverslips in 24 well plates and differentiated
as described above. Electrophysiological and calcium imaging
data have been obtained from cells plated on 33 coverslips
during three independent rounds of differentiation. On the day
of recording, a coverslip was transferred to a custom made
chamber whose bottom was a 0.1 mm-thick coverslip. Cells were
visualized using a CCD camera (Leica DFC350 FX) connected
to an inverted microscope (Leica DMI 4000) equipped with a
63x objective and controlled by Advanced Fluorescence software
(Leica MS). Cells were continuously superfused with Tyrode
extracellular saline containing (in mM): NaCl, 130; KCl, 5; CaCl2,
2; MgCl2, 0.5; glucose, 10; HEPES, 10; pH 7.4 with NaOH.
Cells were recorded by the perforated-patch technique using
pipettes filled with a 270µg/ml solution of amphotericin B in
pseudo-intracellular saline containing (in mM): KCl 140; NaCl,
10; pipes, 10; pH 7.2 with KOH. Due to the similar intra and
extracellular chloride concentrations and sodium and potassium
ionsmobilities in solution, no corrections weremade for junction
potentials. Despite the higher series resistance than whole-cell
recordings, perforated-patch recording series resistances <80
MΩ proved satisfactory for recording slowly-activating Voltage-
gated Potassium Channels (VGKC)-mediated currents from cells
with input resistance over 1 GΩ . The use of a voltage-ramp
protocol avoided the problems of slow membrane charging
when recording fast-activating calcium and barium currents.
The VGKC blocker 4-aminopyridine (4-AP) was dissolved in
Tyrode at 3mM final concentration. NS-1643 was prepared as
a 6mM stock solution in DMSO and dissolved to 30µM final
concentration (0.5% DMSO v/v) in Tyrode containing 3mM 4-
AP, with small changes in osmolarity. Blockers were applied via
a 1,000 µl pipette tip positioned close to the recorded cell using
a mechanical micromanipulator. A six-ways manifold equipped
with electrovalves controlled solutions changes.
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Voltage-Gated Inward and Outward Current
Recordings and Analysis
Currents were recorded using an EPC-8 amplifier (HEKA)
and filtered by the EPC-8 before sampling by the A/D
converter (LIH8+8; HEKA). The LIH8+8 D/A converter
also generated the voltage stimuli. Acquisition and voltage
stimuli were generated by Patchmaster (HEKA). Inward
current through calcium channels were activated by
ramping the voltage from−90 to +80mV in 270ms,
before returning to −90mV. To reduce noise, 16 sweeps,
applied every 5 s, were averaged. The ramp currents
were filtered at 1 kHz by a 3-pole Bessel filter before
sampling at 5 kHz. When using barium to maximize
inward currents through calcium channels, we increased
membrane resistance to reduce voltage errors associated
with voltage partitioning through the series resistance using
extracellular saline containing (in mM): NaCl, 80; KCl, 5;
tetraethylammonium (TEA)-chloride 30; BaCl2, 20, HEPES, 10;
pH 7.4 with NaOH.
Outward currents were activated, from a holding of−80mV,
by 2s-long voltage steps ranging from−70 to +70mV. Currents
were filtered at 0.3 kHz by a 3-pole Bessel filter before sampling
at 1 kHz.
Membrane resistance and capacitance assessment: after initial
fast capacitance compensation at the time of gigaseal formation,
we monitored amphotericin B incorporation by monitoring
amplitude and kinetics of capacitive transients. To quantify
membrane capacitance, transient capacitive currents generated
in response to 45 ms-long 20 mV-voltage steps from a
holding potential of−90mV, were sampled at 50 kHz, filtered
at 5 kHz, and numerically integrated using the steady-state
current at−70mV as a baseline to provide the total charge
(1Q) transferred to the membrane to set the 20mV voltage
change (1V). The ratio 1Q/1V then provides the membrane
capacitance for each cell recorded. To reduce noise 64
sweeps were averaged. The ratio between 1V and the net
current increase (the difference between currents measured at
the end of the 45 ms-long pulse and the holding current
at−90mV) provided the cell membrane resistance. Membrane
conductance (G) was computed as the reciprocal of the
membrane resistance.
Electrophysiological data were analyzed and plotted using
Origin 8.5 (Microcal).
For inward current analysis, we measured net current
intensities as the difference between current intensities at the
peak of the inward deflection (close to +10mV) and the current
at the same potential of the peak inward deflection extrapolated
from the linear fit to the ramp current.
For the analysis of VGKC, we considered both steady-state
currents averaged during the last 200ms of every 2s-long voltage
step (200 points) and tail currents. For tail currents analysis,
due to their reduction in CLN1 overexpressing cells for voltages
positive to+30mV, we averaged values over a 20ms-long interval
centered at the peak of the tail current generated by the 2s-long
activating step, that in most cells occur at +30mV. For each
2s-long activating voltage, the fractional activation [FA(V)] was
computed according to:
FA(V) =
I (V) − I−70
Imax − I−70
(1)
I(V) is the tail current measured at a given activating voltage,
I-70 is the tail current measured at−70mV, and Imax is the
maximum tail current. Considering that I (V) = G (V)•(V−EK)
where G(V) is the voltage-dependent membrane conductance
and EK is the Nernst potential for potassium ions, FA(V) values
are proportional to the fractional activation of conductance









V0.5 is the voltage that activates 50% of the maximum
conductance, and S is the inverse slope factor that affects the
steepness of GFA(V) activation.
Calcium Imaging
A coverslip was washed twice with PBS and then incubated for
25’ at room temperature in 5µM Fluo-4. DMSO concentration
was 0.1%. Fluo-4 fluorescence was elicited by the excitation light
provided by a 40 nm-wide bandpass filter centered at 470 nm. The
emission light, selected by a 50 nm-wide suppression bandpass
filter centered at 525 nm, was separated from reflected excitation
light through a long-pass dichroic mirror centered at 500 nm.
Time-lapse fluorescence was driven by software (Leica AF), using
a 200ms exposure time every 2 s. Voltage-gated calcium channels
were activated by membrane depolarization elicited by switching
for 30 s the perfusion solution from Tyrode to saline containing
(in mM): NaCl, 105; KCl, 30; CaCl2, 2; glucose, 10; HEPES
10; pH 7.4 with NaOH. Control recordings indicate membrane
depolarizations down to about−40mV, close to the change of the
Nernst potential for potassium.
Immunoblotting (WB) Analysis
For immunoblotting analysis, 30 µg of RIPA-extracted cellular
lysate were separated in polyacrylamide gels, transferred on to
PVDF membrane and then probed with primary antibodies
over-night at 4◦C. Anti-rabbit IgG, HRP-linked F(ab’)2 fragment
antibodies (GEHealthcare) were utilized as secondary antibodies;
chemiluminescent detection was performed by Immobilon
Western Chemiluminescent HRP Substrate (Merck-Millipore)
and images were acquired by UVITEC Q9 Alliance Advanced
platform. Densitometric, semi-quantitative analysis was carried
out by Fiji software. Primary antibodies used for WB were
two rabbit anti-CACNA2D2 antibodies, which recognize either
the amino acid residues 850–865 of the protein (1:2000,
purchased by Alomone) or the amino acid residues 19-35
(1:2000, purchased by Biorbyt); a rabbit anti-GAPDH polyclonal
antibody (1:10.000, Sigma-Aldrich), was used as loading control.
To assess the specificity against CACNA2D2 residues 850–865,
1 µg of antibody was incubated with 1 µg of corresponding
antigenic peptide supplied by vendor in TBS with 1% no fat
dry milk at RT for 1 h; then, the mixture was diluted to reach
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the appropriate dilution factor in TBS with 0.1% Tween20,
1% not fat dry milk and 0.05% NaN3 and the incubation
was prolonged over night at 4◦C on rotation. In parallel, a
mixture with 1 µg of antibody was prepared following the same
procedure. Finally, mixtures were used to probe two identical
membranes and the immunoblotting analysis was performed as
described above.
De-glycosylation Assay by PNGase F
To remove N-glycosylated residues, 30 µg of protein lysates
were precipitated in cold absolute methanol at −20◦C for 2 h
and centrifuge at 20,000 × g for 30min at 4◦C. Pellets were
resuspended in 5µl of buffer containing 0.5% β-mercaptoethanol
and 1% SDS, sonicated and boiled for 5min. Then, samples were
added with 10µl H2O, 1.5µl 20% CHAPS and with either 3µl of
TABLE 1 | Differentially expressed genes (DEGs) of SH-CLN1 transcriptomic profile coding for subunits of voltage-gated calcium channels (VGCC) and voltage-gated
potassium channels (VGKC).
Family Gene Alias Gene Name SH-Mock SH-CLN1
FPKM FPKM log2FC q-value




CACNA2D2 α2δ-2 Calcium voltage-gated
channel auxiliary subunit
alpha2delta 2
132.30 61.13 −1.11 0.001
CACNA2D3 α2δ-3 Calcium voltage-gated
channel auxiliary subunit
alpha2delta 3
1.86 7.11 1.94 0.001
Calcium channel auxiliary γ
subunits
CACNG2 γ2 Calcium voltage-gated
channel auxiliary subunit
gamma 2




KCNA3 Kv1.3 Potassium voltage-gated
channel subfamily A
member 3
1.26 0.26 −2.25 0.002
KCNB1 Kv2.1 Potassium voltage-gated
channel subfamily B
member 1
2.78 1.23 −1.18 0.001
KCNH4 Kv12.3 Potassium voltage-gated
channel subfamily H
member 4
1.50 0.67 −1.16 0.006
KCNH6 Kv11.2 Potassium voltage-gated
channel subfamily H
member 6
16.04 7.82 −1.04 0.001
KCNQ3 Kv7.3 Potassium voltage-gated
channel subfamily Q
member 3
0.93 0.17 −2.46 0.001
KCNQ5 Kv7.5 Potassium voltage-gated
channel subfamily Q
member 5
1.95 4.46 1.20 0.029
Potassium two pore domain
channels
KCNK1 K2P1.1 Potassium two pore domain
channel subfamily K
member 1
19.93 7.27 −1.46 0.001
KCNK3 K2P3.1 Potassium two pore domain
channel subfamily K
member 3
6.84 3.13 −1.13 0.001
KCNK6 K2P6.1 Potassium two pore domain
channel subfamily K
member 6
1.82 0.86 −1.09 0.015
Potassium inwardly
rectifying channels
KCNJ2 Kir2.1 Potassium inwardly
rectifying channel subfamily
J member 2
2.14 0.71 −1.59 0.003
DEGs of SH-CLN1 transcriptomic profile, coding for either Calcium or Potassium channel subunits, are reported (|log2FC| > 1, q-value < 0.05). For a wider compendium of VGCC and
Potassium channels encoding genes expressed in mock and SH-CLN1 cell lines, see Supplementary Materials and Supplementary Tables 1, 2.
Family, Channel Gene Family; Gene, NCBI Gene Symbol; Alias, Alternative name (including symbol according NC-IUPHAR -Nomenclature Committee of the International Union of
Pharmacology); Gene Name, HGNC Approved Name; FPKM, fragments per kilobase of exon per million fragments mapped; log2FC, log2 fold change (SH-CLN1 vs. SH-mock); q-value,
false discovery rate (FDR).
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PNGase F (Sigma-Aldrich) or 3 µl of H2O and finally incubated
over-night at 37◦C. Before loading gels, samples were diluted in
4X Laemli buffer, sonicated, boiled for 5min and finally resolved
by SDS-PAGE under denaturing conditions.
Immunofluorescence Assay (IF)
Cell grown on coverslips coated by MaxGel (Sigma-Aldrich)
were fixed with either cold absolute methanol (for KNCH4 IF)
or with 4% paraformaldehyde (for CACNA2D2 IF). Coverslips
were then blocked with Normal Goat serum and incubated with
primary antibody over-night at 4◦C. Primary antibodies used
for IF were two rabbit polyclonal antibodies, anti-CACNA2D2
(1:500) and anti-KCNH4 (1:50; all purchased by Biorbyt). To
detect bound primary antibody, host species-related secondary
antibodies conjugated either with AlexaFluor 488 or 594
dyes (Molecular Probes, Thermo Fisher) were used whereas
nuclei were counterstained with 5µg/ml DAPI (4’,6-diamidino-
2-phenylindole dihydrochloride, Sigma-Aldrich). Images were
acquired by an AxioLab microscope (equipped with an AxioCam
and AxioVision 4.3 software, Zeiss). In addition, confocal
microscopy analysis was performed on a LEICA TCS-SP5
inverted confocal microscope using a high NA oil immersion
40x objective; images were acquired by LasX software and
further analyzed by Fiji. For quantitative evaluation, cells were
selected by ROI and assessed in all z-planes. The number
of CACNA2D2 immunolabelled dot structures were manually
counted and tracked in all planes. To evaluate fluorescent
intensity of KCNH4, corrected total cell fluorescence (CTCF)
were calculated as follows: Integrated Density—(ROI area X
mean gray value fluorescence of background).
Statistical Analysis
For the electrophysiological study, we preliminarily assessed the
deviation of data from a normal distribution by the Shapiro-Wilk
test. In case of deviation, two samples comparisons were carried
out by the non-parametric Mann-Whitney U-test. We used
ANCOVA to evaluate the impact of categorical variables, such
as genotype and charge carrier, and continuous variables such as
membrane capacitance or days after completing differentiation.
In case of multiple drug applications to the same cell, two-
way ANOVA with repeated measurements in time evaluated
the significance of the observe effects. In case of significant
effects, post-hoc comparisons were carried out by t-tests using the
residual variance generated by either ANCOVA or ANOVA and
applying the Bonferroni’s correction for multiple comparisons.
For biochemical and morphological quantitative evaluations,
statistical analyses and representation of data were carried out
by Prism 8 (GraphPad Software, San Diego CA). For WB,
protein isolation was performed at least in three independent
experiments of neuronal differentiation; densitometric data
were presented as mean ± standard deviation (SD) and
statistical significance was analyzed by two-way ANOVA. For
immunofluorescence analysis, we compared mock- and CLN1
transfected cells by either two-tailed unpaired t-test or by Mann-
Whitney U-test following ascertainment of normal distribution
of data by Shapiro-Wilk normality test.
RESULTS
Bioinformatic Investigation of the
Transcriptome of CLN1 Overexpressing
Cells: Focus on Voltage-Gated Ion
Channels
Bioinformatic data of the transcriptome of RA-NBM
differentiated SH-CLN1 cells revealed a meaningful
association of their transcriptomic profile with GO terms
related to synaptic functioning and ion channel activity
(Supplementary Figures 1, 2). We focused on DEGs coding
for subunits of Voltage-gated Calcium Channels (VGCC) and
Voltage-gated Potassium Channels (VGKC or Kv), which play
relevant role in neuronal excitability (Table 1).
In reference to VGCC, CLN1 overexpression affects
the expression of two genes, namely CACNA2D2 and
CACNA2D3, coding for two different α2δ subunits, which
were found to be down- and up-regulated, respectively. It
is of note that these two DEGs belong to the subfamily
of Auxiliary Alpha2Delta Subunits, which enclose
four genes only (three expressed in our cell system;
Supplementary Table 1). No significant changes in the
expression of genes encoding other VGCC subunits were
observed (Supplementary Table 1).
According to GO categories 10 DEGs of SH-CLN1
transcriptome code for different potassium channels and
6 of them belong to VGKC (Kv) subfamily. Taking into
account the total number of Kv genes expressed in mock
and SH-CLN1 cells (n = 22), the percentage of dysregulated
Kv DEGs in CLN1 overexpressing cells was about one-third
(Supplementary Table 2).
Electrophysiological Properties of
Differentiated Mock and SH-CLN1 Cells
We selected the perforated-patch technique to assess the
functional impact of the dysregulated expression of genes
coding for VGIC upon CLN1 overexpression. This approach
minimizes intracellular milieu changes that may affect VGIC
during long recordings (longer than 30min) required
to evaluate both VGCC and VGKC through the serial
applications of blockers/modulators. We initially evaluated
the possible occurrence of unspecific effects in response to
CLN1 overexpression. Specifically, we compared the basic
electrophysiological properties of differentiated SH-SY5Y cells
(see methods), either mock-transfected or overexpressing CLN1.
Data in Figure 1 plot currents evoked in response to a 45ms-long
voltage pulse from−90 to−70mV to estimate cell membrane
capacitance and resistance. Both mock- (Figure 1A) and CLN1-
(Figure 1B) transfected cells had similar 0-current levels (a
proxy for the resting membrane potential) close to−90mV. The
average (±SEM) holding currents at−90mV were−0.38 ± 0.15
and−0.35 ± 0.16 pA/pF for mock and CLN1 cells, consistent
with the notion of similar membrane potentials for mock and
CLN1-overexpressing cells. Themock cell membrane capacitance
of 28 pF (Figure 1C), twice the 14 pF of the CLN1-transfected
cell (Figure 1D), indicates a large reduction in the plasma
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FIGURE 1 | (A,B) Bright field pictures of differentiated SH-SY5Y cells, either mock- (A) or CLN1-transfected (B), during perforated patch-clamp recording. (C,D)
Response of cells in (A,B) to 45 ms-long voltage steps from−90 to−70mV for assessment of membrane resistance and capacitance. The transient currents are larger
in the mock-transfected (C) than in wtCLN1-transfected cell (D), corresponding to membrane capacitance (Cm) of 28 and 14 pF, respectively. (E) Membrane
(Continued)
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FIGURE 1 | capacitance is significantly higher in mock- (open circles) as compared to CLN1-transfected (filled circles) cells (***P < 0.001, Mann-Whitney U-test). (F)
Symbols plot Cm values for mock (open circles) and CLN1-transfected (filled circles) cells as a function of days after completing the differentiation protocol. Straight
lines plot best fit to mock- (tick continuous line) and CLN1-transfected (dashed line). One-way ANCOVA found a significant effect of genotype [F (1,27) = 12.81, P =
0.0013], but not of days after differentiation [F (1,26) = 0.0072, P = 0.921]. (G) Datapoints plot membrane conductance values (see section voltage-gated inward and
outward current recordings and analysis in Materials and Methods) of mock (open symbols) and CLN1-transfected (filled symbols) cells. *P < 0.05 by two-tailed
independent t-test (t = 2.497 with 28 df, P = 0.0187). (H) Membrane conductance values normalized to membrane capacitance (pS/pF) of mock (open circles) and
CLN1-transfected (filled symbols) cells. Average values di not differ significantly (t = 0.72804 with 28 df, P = 0.473 by independent t-test). (I) Datapoints plot
normalized conductance data from mock- (open circles) and CLN1-transfected (filled circles) cells as a function of membrane capacitance. Best-fitting lines had similar
slopes of 0.422 and 0.195 pS/pF for mock- (thick continuous) and CLN1-transfected (dashed line) cells. One-way ANCOVA indicate lack of significant effects by both
genotype [F (1,27) = 0.24, P = 1.0000] and Cm [F (1,26) = 0.17, P = 0.6835]. (J) Datapoints plot normalized conductance values as a function of days after
differentiation for mock (open circles) and CLN1-transfected (filled circles) cells. Straight lines plot best fit mock- (thick) and CLN1-transfected (dashed). One-way
ANCOVA indicates both genotype [F (1,27) = 0.5, P = 0.4856] and days after differentiation [F (1,26) = 0.15, P = 0.7017] do not reach significance.
membrane surface in response to CLN1 overexpression. Data
in panel E depict the distributions of membrane capacitances
(Cm) measured in 15 mock- and 15 CLN1-transfected cells,
indicating the significant reduction in the cell surface induced
by CLN1 overexpression (P = 0.0007 by Mann-Whitney U-test).
In Figure 1F, linear regression fits of membrane capacitance as
a function of days after differentiation indicate similar slopes
(−1.08 and −0.98 pF/day for mock- and CLN1-transfected cells,
respectively). Analysis by one-way ANCOVA for the effects of
genotype and time after differentiation confirmed a significant
effect of genotype [F(1,27) = 12.81, P = 0.0013], while the effect
of days elapsed after completing the differentiation protocol did
not reach significance [F(1,26) = 0.007, P = 0.9211). Consistent
with their larger membrane capacitance, mock cells also had
significantly higher membrane conductance than CLN1 cells (t
= 2.497 with 28 df, P = 0.0187 by two-sided independent t-test,
Figure 1G). Despite the large difference in plasma membrane
area, average (±SEM) normalized conductance of 35.13 ± 3.78
and 31.93 ± 2.26 pS/pF for mock- and CLN1-transfected cells,
respectively, did not differ significantly (t = 0.72804 with 28 df,
P = 0.473 by independent t-test) suggesting that increased levels
of CLN1 do not lead to unspecific cell damage (Figure 1H).
We also tested the impact on normalized conductance of
membrane capacitance, an index of cell size, and days after
differentiation. As shown in panel I, plotting normalized
conductance data from mock- and CLN1-transfected cells as a
function of membrane capacitance, best-fitting lines had similar
slopes (0.422 and 0.195 pS/pF for mock-and CLN1-transfected
cells, respectively). One-way ANCOVA indicates that neither
genotype [F(1,27) = 0.24, P= 1.0000], nor membrane capacitance
[F(1,26) = 0.17 P = 0.6835] had significant effects, suggesting
that the number of channels for plasma membrane unit area
is largely unaffected by differences in cell size, irrespective of
CLN1 overexpression. Data in panel J, plotting normalized
conductance values as a function of days after differentiation,
were interpolated by best-fitting straight lines with slopes of
0.387 and−0.302 pS/pF for mock- and CLN1-transfected cells.
One-way ANCOVA indicates that neither genotype [F(1,27) =
0.5, P = 0.4856], nor days after differentiation [F(1,26) = 0.15, P
= 0.7017] had significant effects, suggesting that the number of
membrane channels for plasma membrane unit area is largely
unaffected by the time elapsed after differentiation, irrespective
of CLN1 overexpression.
Voltage-Gated Calcium Channel
Electrophysiological Investigations and Intracellular
Ca2+ Flux
To assess the functional relevance of the dysregulated expression
of genes coding for VGCC, we compared calcium currents in
differentiated SH-SY5Y cells, both SH-mock and SH-CLN1 cell
lines. Transcriptomic data do not show a significant change
of specific pore-forming subunits. We then opted for a quick
evaluation of inward currents using a voltage-ramp protocol,
rather than adopting the usual voltage step protocol used to assess
the kinetics and the voltage dependence of VGCC and resolve the
contribution of specific isoforms.
Sweeps in Figure 2 plot currents evoked in response to a
voltage ramp (see inset between A and C) in representative
cells either mock- (B) or CLN1-transfected (D) cells recorded in
Tyrode’s solution (blue and cyan traces in B and D, respectively)
containing 2mM CaCl2. In the range from−20 to−10mV, small
inward humps are present in both cells, but a second inward
deflection between 0 and +10mV is present in the mock cell
only. To evaluate whether these small inward currents represent
genuine Ca2+ currents, we exploited the higher permeability
of Ba2+ through VGCC. In the presence of 20mM Ba2+ as
charge carrier, a larger inward current, peaking close to 10mV,
flows in the representative mock cell than in Tyrode (pink and
blue sweeps in Figure 2B, respectively). Ba2+ does not lead
to a large inward current increase in the representative CLN1
overexpressing cell (purple sweep in Figure 2D).
Data in panels 2E and 2F illustrate the difference between
mock and CLN1-transfected cells when using Ba2+ as charge
carrier. Average currents normalized to membrane capacitance
from 9 mock- and 9 CLN1-transfected cells (Figure 2E, thick
blue, and cyan traces, respectively) showed similar amplitudes
at every voltage when recorded in Tyrode. On the other hand,
a remarkable difference was observed for currents recorded
in the presence of 20mM Ba2+ from 9 mock- and 4 CLN1-
transfected cells (Figure 2F, thick continuous pink and purple
traces, respectively), with a large inward current peaking at
about +10mV in the mock-transfected cells only. Symbols in
Figure 2G plot peak inward currents measured in mock (blue
and pink) and CLN1 overexpressing (cyan and purple) cells,
either in 2mM Ca2+ (Tyrode, blue and cyan circles) or 20mM
Ba2+ (TEA/Ba/Cs, pink and purple symbols) as a function of
days after differentiation. A 2-way ANCOVA found significant
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FIGURE 2 | (A,C) Bright-field images of a mock-transfected (A) and a CLN1-transfected (C) cell during perforated-patch recording by a patch pipette. (B) Traces plot
representative currents, recorded from the cell in (A), in response to a voltage ramp [see the thick trace in the inset between (A) and (C)]
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 December 2020 | Volume 14 | Article 569598
Demontis et al. Voltage-Gated Currents and CLN1/PPT1 Overexpression
FIGURE 2 | in either Tyrode (blue traces) or Ba2+/TEA solutions (magenta). (D) Traces plot representative currents, recorded from the cell in (C), in response to a
voltage ramp [see inset between (A) and (C)] either in Tyrode (cyan) or in Ba2+/TEA solutions (purple). In (B,D), each trace is the average of 16 sweeps, recorded at
5s-intervals. (E) Continuous and dashed traces plot average ramp normalized currents (pA/pF) and their standard error, respectively, from mock- (blue, n = 9) and
CLN1-transfected (cyan, n = 9) cells in Tyrode. (F) Continuous and dashed traces plot average ramp currents and their standard error, respectively, from mock- (pink,
n = 9) and CLN1-transfected (purple, n = 4) cells in Ba2+/TEA solution. (G) Symbols plot normalized inward current amplitudes for mock cells in either
Ca2+-containing (blue) or Ba2+-containing (pink) saline and CLN1-transfected cells in either Ca2+-containing (cyan) or Ba2+-containing (purple) saline. Note axis break
from−0,38 to−1,0 pA/pF. Two-way ANCOVA for the effects of genotype and charge carrier and days after differentiation covariant indicates significant effects of both
genotype [F (1,26) = 6.05, P = 0.0209] and charge carrier [F (1,26) = 17.34, P = 0.0003], with no significant effects for their interaction [F (1,26) = 1.45, P = 0.2394] as
well as for the time after differentiation [F (3,23) = 0.23, P = 0.8745]. (H) post-hoc comparisons by t-test using Bonferroni’s correction found significant differences
between currents recorded from mock-transfected cells using either Ba2+ or Ca2+ as charge carrier (**t = 4.314 with 16 df, P < 0.01) and between currents recorded
from mock- and CLN1-transfected cells using Ba2+ as charge carrier (*t = 3.012 with 11 df, P < 0.05). Note axis break from−0,38 to−1,0 pA/pF.
effects of both genotype [F(1,26) = 6.05, P = 0.0209] and
charge carrier [F(1,26) = 17.34, P = 0.0003], with no significant
effects for their interaction [F(1,26) = 1.45, P = 0.2394] as
well as for the time after differentiation [F(3,23) = 0.23, P
= 0.8745]. As shown in Figure 2H, post-hoc t-tests found a
significant difference for charge carrier in mock cells (
∗∗
t =
4.314 with 16 df, P < 0.01) and between mock- and CLN1-
transfected cells in Ba2+ (∗t = 3.012 with 16 df, P < 0.05).
A similar analysis on the impact of membrane capacitance
(Cm) on the effects of genotype and charge carriers on inward
current amplitude (not shown) indicates a significant effect
of charge carrier [F(1,26) = 16.8, P = 0.0004], but neither
genotype [F(1,26) = 2.71, P = 0.1118], nor the interaction
charge carrier/genotype [F(1,26) = 1.95, P = 0.1744] had
significant effects.
Considering that we observed differences in inward currents
between mock- and CLN1-transfected cells in the presence of
high concentrations of external Ba2+, we used calcium imaging to
provide an independent confirmation of CLN1 impact on VGCC
in the presence of physiological levels of external Ca2+.
The application of saline containing 30mM KCl to mock-
transfected cells in Figure 3A generated a large increase in
Fluo-4 fluorescence (Figure 3B). On the other hand, 30mM
KCl induced fluorescence increase in CLN1-transfected cells
(Figures 3D,E) of reduced intensity as compared to mock
cells. The time-course of fluorescence (F) normalized to basal
levels (F0) for two mock and two CLN1 overexpressing cells
(see panels A, B, and D, E above) is plotted in Figure 3C
and 3F, respectively. Note that the kinetics of fluorescence
decay in both mock and CLN1 overexpressing cells fall within
the range observed in both genotypes. Mean values (± 1
SEM) of the increase in fluorescence normalized to basal
fluorescence (1F/F0) measured in mock- (empty circles) and
CLN1-transfected (filled circles) cells are plotted as a function
of days after differentiation in Figure 3G. A one-way ANCOVA
indicates a significant effect of genotype [F(1,170) = 5.97, P =
0.0156], while the effect of time after differentiation was not
significant [F(1,169) = 2.63, P = 0.1067]. Dot-plot in Figure 3H
shows that a large fluorescence increase may occur in both
mock- and CLN1-transfected cells, but the significant difference
(∗P = 0.0156 by ANCOVA) provides independent support
to the notion that CLN1-transfection reduces the number of
functional VGCC.
Expression of the VGCC Subunit
CACNA2D2
We subsequently investigated whether the downregulation of
CACNA2D2 in CLN1 overexpressing cells led to a reduction
of the expression of the corresponding protein CACNA2D2
(also known as α2δ-2), a subunit of VGGC necessary for their
appropriate functioning. We utilized the rabbit polyclonal
antibody which recognizes the amino acids residues 850–
865. Semi-quantitative immunoblotting analysis of lysates
extracted from differentiated CLN1-transfected cells pinpointed
a significant reduction of the 170/140 and 85 kDa bands as
compared to mock lysates, in agreement with CACNA2D2
downregulation (Figures 4A,B). A de-glycosylation assay
confirmed that the 170/140 and 85 kDa bands corresponded
to glycosylated isoforms of CACNA2D2, since the PNGase F
treatment induced a definite shift in the molecular weight of
these two bands (Figure 4C). Moreover, a modulation in their
expression was also evident under different culture conditions,
in particular an upregulation was evident following RA-NBM
differentiation for both cell lines, especially in mock cells.
Pre-incubation of the antibody with the corresponding antigenic
peptide abolished the immunoreactivity, in accordance with
the specific binding of this antibody (Supplementary Figure 3).
Similar WB findings (namely, immunoreactive bands and
signal modulation between mock and CLN1-trasfected
cells as well as between undifferentiated and differentiated
conditions) were detected using another polyclonal antibody
(Supplementary Figure 4). However, in this case it was
not possible to test the specificity of the antibody with the
corresponding antigenic peptide.
Immunofluorescence assay revealed a bright punctate pattern
in mock cells, mainly in the cell bodies, whereas few dots were
detected in SH-CLN1 cells (Figure 4D). Quantitative evaluation
of immunolabelled cells showed a significant reduction in




CLN1 transfection significantly reduces the expression of KCNH
isoforms subfamily (Kv11 and Kv12) as well as of Kv7 channels
of the KCNQ subfamily of VGKC. These isoforms are expressed
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FIGURE 3 | (A,B,D,E) Superimposed bright-field and fluorescent images collected from mock- (A,B) and CLN1-transfected (D,E) cells in Tyrode (A,D) and during
application of modified Tyrode with 30mM KCl (B,E). (C,F) Time course of fluorescence normalized to the pre-KCl application (F0) for two mock- (C) and two
CLN1-transfected (F) cells from pictures in (B,E), respectively. Thick segments above the experimental traces plot the time of application of saline with 30mM KCl. (G)
(Continued)
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FIGURE 3 | Datapoints plot average 1F/F0 values ±1 SEM for mock (open symbols) and CLN1-transfected (filled symbols) cells as a function of days after
differentiation. One-way ANCOVA indicates a non-significant effect for time after differentiation [F (1,169) = 2.63, P = 0.05]. (H) Plot of changes in normalized
fluorescence values (1F/F0) values for 132 mock- (open circles) and 40 CLN1-transfected (filled circles) cells. The fluorescence increase is significantly higher in mock-
than in wtCLN1-transfected cells (*P < 0.05) by one-way ANCOVA, indicating a significant effect for genotype [F (1,170) = 5.97, P = 0.0156).
by Central and Peripheral Nervous System neurons (Zou et al.,
2003) and carry slowly-activating and deactivating currents.
Sweeps in Figure 5 plot representative currents activated by
2s-long voltage pulses at−80, 0, and +70mV (see inset in
panel B), applied from a holding voltage of−80mV, and
show slowly-activating currents at 0mV in both the mock
and CLN1-transfected cells (cyan sweeps in Figures 5A,B,
respectively). Despite the difference in current amplitudes of
representative mock and CLN1 cells in 5A and 5B, average
normalized currents measured at the end of the 2s-long voltage
step nearly superimpose up to−10mV, diverging for voltage
positive to−10mV, although with substantial SEM (Figure 5C).
To assess whether genotype affects VGKC, outward currents
normalized to membrane conductance were converted into
conductances and fitted by Boltzmann equation (see Equation
2 in the Methods section). Data in Supplementary Figure 5A
plot average normalized conductance with their SEM for mock
(open circles) and CLN1-transfected (filled circles) cells, along
with best fitting Boltzmann equations. Panel SF5B plots the
average inverse slope factors (S) and show that CLN1-transfected
cells (11.92 ± 1.06mV, N = 14) has a significantly steeper
activation than mock cells (17.77 ± 2.36mV, N = 15) (t =
2.206 with 27 df, P = 0.036 by independent t-test). Average
maximal normalized conductances of mock (67.89 ± 17.59
pS/pF) and CLN1-transfected cells (39.81 ± 5.58 pS/pF) in
Supplementary Figure 5C did not differ significantly (t = 1.478
with 27 df, P = 0.151 by two-tailed independent t-test).
Also, the average half-activation voltages of mock (-23.87 ±
7.07mV) and CLN1-transfected cells (-35.79 ± 3.96mV) in
Supplementary Figure 5D did not differ significantly (t = 1.441
with 27 df, P = 0.161). We also evaluated by one-way ANCOVA
whether days after differentiation contribute a quote of variance
that may blur the significant difference between genotypes in
either maximal conductance or half-activation voltage. However,
ANCOVA indicates a lack of significant effect for both genotype
and days after differentiation onmaximal conductance [genotype
F(1,26) = 2.26, P= 0.1448; days after differentiation F(1,25) = 2.63,
P = 0.1174] and half-activation voltage [genotype F(1,26) = 1.95,
P = 0.1744; days after differentiation F(1,25) = 0.03, P = 0.8639].
We considered that several genes in differentiated SH-SY5Y
cells, such as KCNH2, KCNH6, KCNH4, KCNH8, and KCNQ2,
code for VGKC carrying outward currents. In these conditions,
the two-fold reduction of KCNH4 (Kv12.3), a low-expressed
DEG, and the slight downregulation of KCNH8 (Kv12.1; see
Supplementary Table 2) may hardly translate into a significant
decrease in the amplitude of outward currents due to the presence
of Kv11 and other Kv currents of larger amplitude. We tested the
possibility of removing the confounding effects contributed by
other VGKCwith fast-deactivating currents by analyzing the slow
tail currents. Both mock- and CLN1-transfected cells generate
slow tail currents at−50mV with broadly similar kinetics and
amplitudes, as shown for each cell by the cyan and blue sweeps
nearly superimposing, a feature consistent with the expression
of KCNH and KCNQ channels. To address this point, we
measured the slowly decaying tail currents at−50mV. Open and
filled circles in panel 5D plot the fractional activation of tail
currents at−50mV in 15 mock and 13 CLN1-transfected cells,
respectively. Average values of half-activation voltages generated
by best-fits of the Boltzmann equation to conductance data of
each cell indicate a significant difference between mock (-14.6
± 3.8mV, N = 15) and CLN1 (-25.8 ± 3.2mV, N = 13) (t
= 2.1874 with 26 df, P = 0.0379 by two-tailed independent
t-test). Normalized tail current amplitudes in panel E do not
differ between mock (1.30 ± 0.26 pA/pF, N = 15) and CLN1-
transfected cells (1.71 ± 0.26 pA/pF, N = 13) (t = 1.104 with
26 df, P = 0.2799 by independent t-test). One-way ANCOVA
indicates a non-significant effect of either time after completing
the differentiation [F(1,24) = 0.02, P= 0.8887] or genotype [F(1,25)
= 1.09, P= 0.3065]. A similar analysis on half-activation voltages
plotted in Figure 5F indicated that time in culture did not affect
tail-currents half-activation voltages [F(1,24) = 0.01, P = 0.9212],
but confirmed the effect of genotype [F(1,25) = 6.39, P = 0.0182
for genotype]. These results imply that, at any given time, tail
currents of similar amplitude in mock- and CLN1-transfected
cells flow through different combinations of Kv channels.
To address the contribution of different Kv channels to
outward currents, we took advantage of the differential effects of
4-aminopyridine (4-AP), which blocks Kv11 while upregulating
Kv12 channels (Elmedyb et al., 2007; Dierich et al., 2018) and does
not affect Kv7 channels (Khammy et al., 2018).
Currents recorded from mock and CLN1 overexpressing
cells showed opposing responses to the application of 3mM
4-AP. Indeed, the drug did not reduce the amplitude of
currents activated by voltage steps to−70 (Figure 6A) and 0mV
(Figure 6B) in the mock cell recorded 5 days after differentiation,
with reduced amplitude at +70 (compare orange and black
sweeps in Figure 6C). On the other hand, 4-AP (orange sweeps)
strongly suppresses outward currents at both 0 and +70mV
in the CLN1-transfected cells (Figures 6E,F). Inspection of the
representative records in panels B, C, E, and F revealed a
striking difference between mock and SH-CLN1 cells in the
sensitivity of tail currents to 4-AP. The drug barely affected tail
current amplitude in the mock cell, while almost entirely blocked
them in the CLN1 overexpressing cell. However, by day 7 after
differentiation, tail currents of mock cells became sensitive to
4-AP, similar to CLN1 overexpressing cells, as shown for two
representative cells in panels 6G and 6H, respectively. Data in
panel 6I plot the ratio between tail current amplitude in 4-AP
and Tyrode for 14 mock (open symbols) and 10 CLN1-trasfected
(filled symbols) cells. A two-way ANCOVA indicated significant
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FIGURE 4 | Biochemical and morphological investigations of CACNA2D2 expression on mock and CLN1-transfected cell lines. (A) Immunoblot analysis of
CACNA2D2 expression on homogenates of mock- and CLN1-transfected cells, cultured in RA-NBM differentiating medium. A higher expression of both 170/140 and
85 kDa bands was evident in lysates from mock cells as compared to lysates from CLN1-transfected cells. (B) Densitometric evaluation of 170/140 and 85 kDa
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 13 December 2020 | Volume 14 | Article 569598
Demontis et al. Voltage-Gated Currents and CLN1/PPT1 Overexpression
FIGURE 4 | isoforms, which putatively represents two glycosylated isoforms, confirmed a significant reduced expression in differentiated CLN1-transfected cells
compared to mock. Two-way ANOVA followed by Bonferroni multiple comparisons test; **P < 0.01, ****P < 0.0001; I, II, and III represent cellular homogenates from
three independent differentiation experiments. (C) Treatment with PNGase F induced a shift of 170/140 and 85 kDa bands, generating new bands running ∼at
120/110 and ∼70 kDa, respectively (see molecular weight in red). Another band of 60 kDa, present only in the differentiated cells, disappeared following PNGase F
treatment and likely generated a 53 kDa immunoreactive band. A quantitative difference in the expression of 170/140 and 85 kDa bands was also evident between
mock and CLN1- transfected cells, both under undifferentiated conditions and following RA-NBM differentiation. (D) Immunofluorescence assay using the rabbit
polyclonal antibody recognizing the extracellular N-term of the protein showed a clear dot-like pattern on mock cells, mainly localized on the cell body; on
CLN1-transfected cells, the pattern of staining was more diffuse and less cells with immunolabelled dots were observed. The assay was performed without the
permeabilization step in order to visualize the protein exposed on the cell membrane. Scale bar equals to 10µm. (E) The quantitative analysis of immunolabelled cells
showed a higher percentage of mock cells showing at least one dot, as compared to CLN1-transfected cells. ****P < 0.0001, unpaired t-test. (F) In addition, the
number of detected immunolabelled dots was lower in CLN1-transfected cells (N = 82) as compared to mock cells (N = 127). ****P < 0.0001, Mann-Whitney U-test.
effects of both genotype [F(1,21) = 5.78, P = 0.0255] and time
after differentiation [F(1,20) = 9.06, P = 0.0069]. These data may
indicate that the up-regulation of Kv12 channels by 4-AP may
mostly compensate the block of Kv11 channels in mock cells up
to 6 days after differentiation. In contrast, the reduced numbers
of Kv12 channels may prevent the compensation of blocked
Kv11 channels in CLN1 overexpressing cells, and in mock cells
since day seven after differentiation. To test this hypothesis,
we used NS-1643 that, applied after the simultaneous block
of Kv11- and potentiation of Kv12-mediated currents by 4-AP,
effectively blocks currents flowing through Kv12-channels. One-
way ANCOVA did not find significant effects of both genotype
[F(1,21) = 1.69, P = 0.2077] and Cm [F(1,20) = 0.09, P = 0.7673]
on tail ratios (not shown).
As shown in Figures 6J–L, plotting sweeps recorded in the
presence of either 3mM 4-AP (orange) or the combination of 4-
AP + NS-1643 (cyan). Note that NS-1643 nearly abolishes the
tail currents at−50mV in the mock-transfected cell (Figure 6J),
but has marginal effects in the CLN1 overexpressing cell
(Figure 6K) whose tail currents resisted block by 4-AP. Columns
in panel 6L plot average normalized tail current amplitudes,
with their SEM, computed from 6 mock- and 4 CLN1-
transfected cells sequentially recorded in Tyrode (TYR), 4-
AP, and 4-AP in combination with NS-1643 (NS). Two-way
ANOVA for repeated measurements in time indicates a non-
significant difference between genotype [F(1,8) = 2.34, P =
0.1646], consistent with the selection of CLN1 cells whose
tail currents resist block by 4-AP. However, the analysis
indicates significant effects for both treatment [F(2,16) = 24.95,
P < 0.0001] and the interaction between treatment and
genotype [F(2,16) = 4.1, P = 0.0365]. post-hoc analysis by
two-tailed paired t-test with Bonferroni correction for the
number of contrasts indicates NS-1643 significantly reduces
tail currents of mock cells recorded in 4-AP (t = 5.446 with
8 df, P < 0.001).
Expression of the VGKC Subunit KCNH4 (Kv12.3)
We then assessed the expression of a VGKC subunit coded by
KCNH4 (Kv12.3), a DEGs of SH-CLN1 transcriptomic profile.
By using KCNH4 antibody, immunofluorescent assay revealed
an ER pattern of staining shared between both differentiated
mock and CLN1-trasfected cells (Figure 7A). Signal intensity
was much lower in CLN1-trasfected cells as confirmed by CTCF
quantitative analysis (Figure 7B).
Palmitoylation Inquiry
Bioinformatic investigation through Swiss-Palm database (which
collects proteomic studies and related palmitoylated identified
proteins); (Blanc et al., 2019) was carried out to assess whether
channel proteins encoded by DEGs of SH-CLN1 may be
putative targets of PPT1 in vitro. Considering DEGs enclosed
in the three previously analyzed GO terms (namely intrinsic
component of synaptic membrane, voltage-gated ion channel
activity, and modulation of chemical synaptic transmission),
only KCNK1 was found to be palmitoylated (see network in
Supplementary Figure 2). However, the number of putative
palmitoylated ion channels increased if one considers either
palmitoylated ortholog proteins or the presence of cysteine
residues, predicted in silico to be suitable for palmitoylation.
In this view, CACNA2D3 and CACNG2 have orthologs
reported to be palmitoylated. Likewise, CACNA2D2 and KCNH6
contain cysteine predicted to be modified by palmitoylation.
Nevertheless, there is poor evidence supporting a modification
through palmitoylation for most of the ion channels coded by
DEGs identified in CLN1 overexpressing cells.
DISCUSSION
Bioinformatic surveys of the transcriptomic profile of SH-SY5Y
cells, overexpressing CLN1 and differentiated into a neuronal-
like phenotype, disclosed networks of genes involved in two
main neuronal functional modules, namely the acquisition of
morphological neuronal-like features and synaptic compartment
and functioning (Pezzini et al., 2017b). These puzzling findings
were not detected in the same cellular system over-expressing
the most frequent Italian variant of CLN1 (i.e., c.665T>C), and
may indicate that the described events are obtained when the
fully-functional protein is over-expressed, whereas a mutated
protein (no matter which kind of mutations) is “silenced” if
overexpressed (Pezzini et al., 2017b). In this study, we focused
our attention on the dysregulation of genes coding for subunits
of voltage-gated ion channels (either VGCC or Kv, see Table 1).
Results show that CLN1 overexpression induces the remodeling
of the electrophysiological profile of the human neuroblastoma-
derived cell line SH-SY5Y by the selective suppression of a
subset of voltage-gated calcium and potassium currents. The
notion that an increase in PPT1 affects channel proteins outside
the human palmitoylome represents a significant conceptual
advancement toward the identification of PPT1 mechanisms of
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FIGURE 5 | (A,B) Sweeps plot currents recorded from a mock- (A) and a CLN1-transfected (B) cell, in response to 2s-long voltage steps at−70 (magenta), 0 (cyan),
and +70mV (blue), from a holding of −80mV. Tail currents are recorded at −50mV. The inset in (B) plots the voltage stimulation protocol. In (A,B), short dash lines
indicate the 0-current level. (C) Average currents from 15 mock- (open circles) and 15 CLN1-transfected (filled circles) cells with their sem. (D) Data points plot the
average values ± 1 SEM of tail currents fractional activation at −50mV (see Materials and Methods) as a function of the voltage applied during the 2s-long voltage
step preceding the −50mV voltage step. Dashed lines plot best fit of Equation 2 to mock (open circles) and CLN1-transfected (filled circles) data points. Average
half-activation voltages of mock (−14.6 ± 3.8mV, N = 15) and CLN1-transfected (−25.8 ± 3.2mV, N = 13) cells were significantly different (t = 2.187 with 26 df, P =
0.0379) by two-tailed independent t-test. (E) Data points plot tail current amplitudes for mock (open circles) and CLN1-transfected (filled circles) (t = 1.104 with 26 df,
P = 0.2799 by independent t-test). (F) Data points plot tail currents half-activation voltages for mock (open circles) and CLN1-transfected (filled circles) data. One-way
ANCOVA indicates a significant effect of genotype [*F (1,25) = 6.39, P = 0.0182], but time after differentiation did not significantly affect the half-activation voltages
[F (1,24) = 0.01, P = 0.9212].
actions in nerve cells. We are aware of the limitations of this
experimental setting as far CLN1 disease is concerned; therefore
studies on a KO cellular model (using the SH-SY5Y cells)
following a similar methodological approach are in progress in
our laboratories: transcriptomic analysis will lead us to perform
selected functional, biochemical (proteomic) and cell physiology
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FIGURE 6 | (A–C) Sweeps plot currents recorded 5 days after differentiation from a mock cell in response to a 2s-long voltage step−70 (A), 0 (B), and +70 (C) mV
from a holding of −80mV, in Tyrode (black) and Tyrode with 3mM 4-AP (orange). (D–F) As for (A–C) above, but a CLN1-transfected cell. (G,H) Sweeps plot currents
recorded 7 days after differentiation from a mock (G) and a CLN1-transfected (H) cell in response to 2s-long voltage steps to−70, 0, and +70mV from a holding of
(Continued)
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FIGURE 6 | −80mV, in Tyrode (black) and Tyrode with 3mM 4-AP (orange). (I) Data points plot ratios between tail currents recorded at −50mV in the presence and
in the absence of 4-AP as a function of time after differentiation for 14 mock (empty circles) and 10 CLN1-transfected (filled circles) cells. A two-way ANCOVA
indicated significant effects of both genotype [F (1,21) = 5.78, P = 0.0255] and time after differentiation [F (1,20) = 9.06, P = 0.0069]. (J,K) Each panel plots currents
recorded 5 days after differentiation in 3mM 4-AP (orange) and 4-AP+30µM NS-1643 (cyan) from the mock (J) and the CLN1-transfected (K) cells in (A–C) and
(E–G), respectively. (L) Columns plot average normalized tail current amplitudes, with their SEM, from 6 mock- (open bar) and 4 CLN1-transfected (filled bar) cells
sequentially recorded in Tyrode (TYR), 4-AP, and 4-AP in combination with NS-1643 (NS). Two-way ANOVA for repeated measurements in time indicate significant
effects for drugs [F (2,16) = 24.95, P < 0.0001], but not genotype [F (1,8) = 2.34, P = 0.1646]. The interaction between genotype and drug appears significant [F (2,16) =
4.1, P = 0.0365]. ***P < 0.0001 by post-hoc analysis using a two-tailed paired t-test with Bonferroni correction for NS 1643 effect on tail amplitude in mock cells.
FIGURE 7 | Immunofluorescence analysis of KCNH4 (Kv12.3) in differentiated mock- and CLN1-transfected cells. (A) Immunostaining by KCNH4 antibody revealed
cytoplasmatic structures resembling ER cisternae in both differentiated mock- and CLN1-transfected cells. Bar equals to 10µm. (B) Quantitative analysis of corrected
cell fluorescence intensity (CTCF) by Fiji indicated a meaningful reduction of fluorescence signal in CLN1-transfected cells as compare to mock cells. ****P < 0.0001,
Mann-Whitney U-test.
studies matching the putative results with those obtained in our




Chemical cues, provided by RA-NBM, promote SH-SY5Y
differentiation toward a neuronal phenotype, characterized by
shield-like morphology of their cell body and a long axon
that express synaptic markers (Encinas et al., 2000; Pezzini
et al., 2017a). Previous electrophysiological analysis indicated
a considerable variability between the electrophysiological
profiles of undifferentiated SH-SY5Y (Santillo et al., 2014).
Patch-clamp and calcium imaging data from this study have
shown that most mock SH-SY5Y cells generate voltage-gated
calcium and potassium currents upon culturing in neuronal
differentiation medium, as expected from adult neurons, and
therefore indicate they are suitable for electrophysiological
studies. The slow kinetics of currents and the sensitivity
to drugs such as 4-AP and NS-1643, all agree with the
expression of Kv12 channels by differentiated SH-SY5Y cells.
The notion of membrane currents through Kv12 channels
is intriguing, considering their expression pattern, somewhat
restricted to telencephalic/diencephalic neurons (Zou et al.,
2003). Likewise, the expression of additional members of the
Kv11 subfamily (i.e., KCNH2 and KCNH6) also suggests that
chemical cues promote, in a subset of SH-SY5Y cells at least, the
development of functional properties consistent with a neuronal-
like phenotype. Altogether these findings sustain the successful
neuronal differentiation of SH-SY5Y cells in such experimental
setting. Intriguingly, we found that mock cells progressively
change some of their functional features within a few days after
switching from the RA containing medium to enriched NBM
lacking RA. Specifically, data on Kv currents suggest a progressive
loss of Kv12 channels, with mock cells lacking functional Kv12
channels after days 7 from RA-containing medium removal.
However, the loss of Kv channels, does occur in a selective
way, with cells keeping the expression of functional calcium
channels, according to both patch-clamp and calcium imaging
data, up to 10 days after switching in enrichedNBMmedium. The
mechanisms underlying the differential regulation of calcium
and Kv12 channels by RA-containing medium components are
presently unknown. Beside the roles of specific components,
it is possible that differentiation does not occur in a stepwise
mode, and different ion channels may not start their expression
in a synchronous way. Differentiation may rather occur as a
sequence of steps spaced in time by tightly-controlled delays. In
this case, earliest differentiation events may last longer than those
occurring at later times. In the limited time span of our study, we
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may well find the loss of late-occurring differentiation steps (i.e.
the expression of Kv12 channels), but fail to recognize the loss
of early-occurring steps (i.e. the expression of calcium channels).
Future experiments monitoring the functional expression of
ion channels at earlier differentiation times in RA-containing
medium may address this point, along with data collection at
longer times after completing the differentiation protocol. It is
also relevant to note that the remodeling of KCNH subunits
with time after differentiation in mock cells does not occur at
the expense of tail currents amplitudes, which remain of similar
amplitudes in both mock and CLN1-overexpressing cells. This
observation may indicate that KCNH targeting to the membrane
reflect a role for RA-medium specific factors in promoting
isoform-independent trafficking, similar to the non-significant
decrease of membrane conductance in the range−90/-70mV
with time after differentiation.
Electrophysiological Profiles of
Differentiated SH-CLN1 Cells
Results on normalized membrane conductance provide
independent support to the notion that CLN1 overexpression
does not affect plasma membrane characteristics in a range
of membrane potentials close to resting values. Membrane
potentials close to the Nernst potential for potassium ions, in
bothmock andCLN1-transfected cells, are in accordance with the
same notion (Figure 1). Nevertheless, the number of functional
calcium channels reaching the plasma membrane is substantially
reduced in CLN1-transfected cells, as revealed by both patch-
clamp and calcium imaging data following appropriate stimuli
(Figures 2, 3). Neither time after differentiation, nor membrane
capacitance affects the impact of charge carrier on inward current
amplitudes. However, the ANCOVA, using as a covariate the
membrane capacitance (an index of plasma membrane surface)
indicates Cm reduces the effect of genotype. Considering that
membrane currents were expressed as current densities by
normalization to the cell capacitance, this may indicate that
cell surface independently affects the number of channels
reaching the plasma membrane. Indeed, CLN1-transfected
cells appear to have less elaborated axonal branching, which
may reflect a shortage of sites for channels insertion. However,
immunostaining in SH-SY5Y cells does not have enough
sensitivity to reveal axonal hot spots in either mock or CLN1
overexpressing cells to support this hypothesis.
CLN1 overexpression also significantly reduces the number
of a subset of functional VGKC in the plasma membrane of
differentiated SH-SY5Y cells. The functional properties and the
sensitivity to drugs of these channels are consistent with reduced
Kv12. Altogether, these observations indicate that an increased
PPT1 activity triggers the remodeling of the electrophysiological
profile of SH-SY5Y cells by selectively affecting two distinct
families of VGIC. Data from tail current analysis reveal some
intriguing features of CLN1 overexpression on KCNH channels
regulation. The finding that CLN1 overexpression does not
change tail current amplitude may indicate that the number
of KCNH channels reaching the plasma membrane is tightly
controlled. Expression data indicate KCNH2 and KCNH6
(Kv11.1 and Kv11.2) as the KCNH isoforms with the highest
expression in both mock and CLN1-transfected cells. Assuming
higher gene expression translates into higher protein levels,
which would in turn increase the chance of accessing the
trafficking machinery, we would expect Kv11 channels as the
prevailing currents in both mock- and CLN1-transfected cells.
In contrast, data in Figure 6 indicate that the Kv11 channels
block by 4-AP does not affect tail current amplitudes in mock
cells up to 7 days after completing the differentiation protocol,
while strongly suppressing tail currents in CLN1-transfected cells
at all times after differentiation. These findings may indicate
that in mock cells Kv12 channels may have a preferential
access to the trafficking machinery, thus overcoming Kv11
channels higher expression. This possibility may require further
investigation to assess the correlation between Kv11 protein and
gene expression levels in both mock and CLN1-overexpressing
cells. A different possibility would be that CLN1 overexpression
reduces Kv11 stability in the plasma membrane, ending up with
Kv12 accumulation. However, IF data showing reduced KCNH4
(Kv12.3) staining in CLN1 overexpressing cells does not support
a mechanism primarily based on reduced Kv11 stability.
Correlations Between Bioinformatic Data
and Molecular Findings
The evidence of the expression of selected ion channels
(CACNA2D2, KCNH4, and KCNH6) by SH-SY5Y cells lays
the ground for the electrophysiological study. A relationship
between transcriptomic results and protein expression data was
detected for CACNA2D2 only. Downregulation of the transcript
(log2FC=−1.11) in differentiatedCLN1 overexpressing cells was
associated with lower expression of two isoforms of CACNA2D2
(and especially of the 170/140 kDa isoform) in homogenates
of the same cell line, as compared to differentiated mock cells
(Figure 4A and Supplementary Figure 4). Interestingly, the 170
kDa isoform likely corresponds to the mature, glycosylated
protein exposed to cell surface, which provides the structural
elements required for channel stimulation [Figure 4C and
data in Gurnett et al. (1996), Hoppa et al. (2012)]. The
85 kDa immunoreactive band may represent an intermediate
glycosylated isoform of CACNA2D2 expressed by SH-SY5Y or
a degradation product generated during the harvest of cells.
In our view, the biochemical findings suggest that intracellular
processing of CACNA2D2 and its translocation to the outer
membrane surface of the cell occurred properly even in
differentiated CLN1 overexpressing cells, although less amount
of mature protein may reach the plasma membrane. Altogether
these data are in agreement with the biochemical properties
of CACNA2D2/α2δ-2 previously reported in different cellular
settings (Davies et al., 2010; Neely and Hidalgo, 2014; Dolphin,
2016, 2018; Tedeschi et al., 2016) and consistent with its
expression in SH-SY5Y cells.
As for VGKC, our cell physiology data demonstrated the
decrease in the number of functional channels, whose properties
are consistent with Kv12 channels, reaching the plasma
membrane upon CLN1 overexpression. The investigation of the
KCNH4 was partially achieved by the IF assay, which pinpointed
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a decreased fluorescence intensity of KCNH4 immunostaining
CLN1-transfected cells. These findings are consistent with the
marked expression of the protein in the ER, whereas an evidence
of translocation to the cell membrane has not been demonstrated.
However, the differences in IF intensity are consistent with the
results of RNAseq analysis.
Putatively Impaired Cellular Mechanisms
The observed correlations between bioinformatic data and cell
physiology study raise, however, several questions as for the
pathomechanisms leading to ionic channel malfunctioning in
this experimental setting. It is tempting to hypothesize that
increased PPT1 levels may hamper the functioning of several
subunits of ion channels by changing their palmitoylation state
(Shipston, 2014).
Recent findings pinpointed a molecular link between
PPT1, CSPα/DNAJC5 and some potassium channels. CSPα
is a palmitoylated co-chaperone protein of synaptic vesicles:
mutations in its cysteine string domain lead to an adult-
onset form of Neuronal Ceroid Lipofuscinosis, CLN4 (Nosková
et al., 2011; Zhang and Chandra, 2014; Henderson et al.,
2016). Alterations in CSPα affects the expression of a subset of
palmitoylated K+ channels, namely large-conductance calcium
and voltage-gated potassium (BK) channels, and their related
currents (Jeffries et al., 2010; Kyle et al., 2013; Donnelier et al.,
2015). As discussed in point 4.2 above, the notion that the altered
palmitoylation state of a chaperone protein (along with mis-
localization and accumulation of PPT1) impairs the trafficking to
the plasma membrane of voltage-gated potassium channels bears
a clear relevance to our results.
In silico prediction suggested that several of the channel
proteins identified in our cell model may be palmitoylated.
For instance, CACNA2D2/α2δ-2 and CACNA2D3/α2δ-3 contain
cysteines or have an orthologous protein which has been
identified as palmitoylated (Blanc et al., 2019). Interestingly,
these two α2δ proteins have been affinity purified from a cortical
mouse lysate by using a recombinant PPT1 enzyme, and an
FIGURE 8 | Ingenuity Pathway Analysis of DEGs associated with the overexpression of CLN1-transfected cells revealed a significant involvement of functional
annotations related to “Quantity of Calcium” (predicted inhibited, z-score = −3.108) and “Synaptic Transmission” (predicted inhibited, z-score = −1.279); interestingly,
“Seizures” annotation was also predicted to be activated in our experimental settings (z-score = 1.951). Genes coding for Calcium and Potassium ion channels are in
bold. Notably, CACNA2D2 bridges “Quantity of Calcium” and “Seizures” and supports their predicted activation state.
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altered amount of CACNA2D2 was also detected by a proteomic
approach (Sapir et al., 2019). We cannot rule out that the
observed malfunctioning of calcium channels may be derived
from an incorrect processing of α2δ-2, necessary to drive mature
channels toward plasma membrane domain (Gao et al., 2000;
Dolphin, 2016; Kadurin et al., 2016; Ferron et al., 2018).
Lastly, it remains unsolved the full chain of events in CLN1
disease. One might argue whether the reduced gene expression
represents the consequence rather than the cause of the defective
trafficking of channels. CLN1 overexpression may lead to
accumulation of stacked immature channel proteins, triggering
a feedback mechanism that would switch-off the transcription of
VGIC genes.
However, these issues deserve targeted investigations, which
were beyond the purpose of this study.
Concluding Remarks
Differentiated SH-SY5Y cells, which present a neuronal-like
phenotype, represent a suitable model for electrophysiological
studies in vitro. Overall, data from this study have shown that
CLN1 overexpression in these cells is associated with profoundly
reduced expression of transcripts coding for voltage-gated
calcium and potassium channel subunits. That may provide some
clues as for a potential role of these genes in the pathogenetic
mechanisms related to CLN1 disease.
Patch-clamp profiles of differentiated SH-SY5Y cells have
shown that CLN1 overexpression is associated with selective
remodeling of the electrophysiological properties of these cells;
likewise, calcium imaging studies revealed reduced Ca2+ influx
in accordance with the bioinformatic prediction of CACNA2D2
involvement in this experimental setting. These mechanisms
may be related to and facilitate an onset and maintenance
of the untreatable seizures observed in CLN1 disease as
highlighted by the putative activating role of CACNA2D2
on seizures (Figure 8). These findings require more targeted
experimental work using other cellular systems. Not much
is known of the electrophysiological properties and seizure
activity in CLN1 KO mouse models. However, a protective
role of PPT1 from excitotoxicity was suggested in induced
status epilepticus in rat (Suopanki et al., 2002). Focusing
on abnormal currents and related VGICs investigated in this
CLN1 overexpression study may also contribute to better
understanding the pathomechanisms underlying the untreatable
epilepsy present in CLN1 disease (Vanhanen et al., 1997).
The biochemical characterization of α2δ-2 did not reveal post-
translational changes of the protein, but decreased amounts
of the expressed protein in the homogenates of differentiated
cells overexpressing CLN1 in line with its reduced mRNA
expression. Likewise, the negative effect on axonal growth of
CLN1 overexpression in SH-SY5Y cells leading to reduced
neuronal plasma membrane surface, may result in less protein
translocated to the membrane, and it does not seem to be directly
related to changes in CACNA2D2 expression. CACNA2D2 is
involved in axonal growth and branching in an age regulated
manner in murine dorsal ganglia neurons. Namely, CACNA2D2
overexpression is associated with inhibition of axonal growth
and elongation, whereas a 2 bp deletion of the gene in the
ducky-2j mutant mouse promotes axonal growth and affects
collateral branching (Tedeschi et al., 2016). Another major
function ascribed to α2δ subunits (including α2δ-2) is to
modulate the differentiation of presynaptic endings (Dickman
et al., 2008; Kurshan et al., 2009), and to induce the formation
of synapses both in vitro and in vivo (Eroglu et al., 2009).
Altogether, data from the literature indicate a relevant role for
α2δ-2 in axonal compartments (such as the synaptic junctions
at the nerve endings and the plasma membrane), which are
primarily involved in the electrical activities of neurons. It is
unclear if the impaired electrical activity associated with reduced
α2δ-2 expression in SH-SY5Y overexpressing CLN1 relates to
the abnormal firing of neuronal cells in other experimental
settings. It is worth remarking, however, that biallelic variants
in CACNA2D2 are detected in an early onset form of epileptic
encephalopathy, which shares some clinical features with CLN1
disease (Brill et al., 2004; Ivanov et al., 2004; Punetha et al., 2019).
Recent evidence suggests that the effects ofCACNA2D2 on axonal
growth and elongation as well as on synaptic formation are
inhibited by pregabalin, a drug which targets the α2δ-2 subunit
and which is used in several neurological conditions, including
epilepsy (Tedeschi et al., 2016). Testing the efficacy of this drug
in cellular and animal models of PPT1 deficiency might become
a step forward to cope with severe neuronal dysfunction observed
in CLN1 disease. Among open questions to be answered remain
the mechanisms leading to the remodeling of functional channels
on the plasma membrane associated with overexpressed CLN1
and the putative role CACNA2D2 on neuronal dysfunction and
pathology in CLN1 disease.
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